Jeff Bezos Stock Portfolio: 5 Companies and Startups

3. Denali Therapeutics Inc. (NASDAQ:DNLI)

Market Capitalization as of February 19, 2023: $4.15 billion

Number of Hedge Fund Holders in Q3 2022: 22

Denali Therapeutics Inc. (NASDAQ:DNLI) is a biotechnology company that focuses on neurological disorders such as Parkinson’s disease and Alzheimer’s disease. The firm is based in San Francisco, California.

Insider Monkey took a look at 920 hedge fund portfolios for 2022’s third quarter to discover that 22 had bought the firm’s shares.

Denali Therapeutics Inc. (NASDAQ:DNLI)’s largest investor is Eli Casdin’s Casdin Capital which owns 1.3 million shares that are worth $36 million.

Follow Denali Therapeutics Inc.